2023 Purple Reenrollment Cycle

Disease Programs Open for 2023 Reenrollment: Purple Group

  • Acromegaly Copay Assistance Program
  • Acute Myeloid Leukemia Copay Assistance Program
  • Alpha-1 Antitrypsin Deficiency Financial Assistance Program
  • Amyloidosis Financial Assistance Program
  • Asthma Copay Assistance Program
  • Atypical Hemolytic Uremic Syndrome Financial Assistance Program
  • Bladder Cancer Copay Assistance Program
  • Chronic Granulomatous Disease Financial Assistance Program
  • Cold Agglutinin Disease Financial Assistance Program
  • Crohn’s Disease Copay Assistance Program
  • Cystinosis Financial Assistance Program
  • Duchenne Muscular Dystrophy Financial Assistance Program
  • Fabry Disease Financial Assistance Program
  • Gaucher Disease Financial Assistance Program
  • Gout Financial Assistance Program
  • Hereditary Angioedema Financial Assistance Program
  • Hunter Syndrome Financial Assistance Program
  • Hypophosphatasia Financial Assistance Program
  • Idiopathic Pulmonary Fibrosis Copay Assistance Program
  • Lambert-Eaton Myasthenic Syndrome Financial Assistance Program
  • Long Chain Fatty Acid Oxidation Disorders Financial Assistance Program
  • Lysosomal Acid Lipase Deficiency Financial Assistance Program
  • MPS VII – Sly Syndrome Financial Assistance Program
  • Mucopolysaccharidosis Type I – MPS I Financial Assistance Program
  • Myasthenia Gravis Financial Assistance Program
  • Neuromyelitis Optica Spectrum Disorder Financial Assistance Program
  • Nontuberculous Mycobacterial Lung Disease Copay Assistance Program
  • Ovarian Cancer Copay Assistance Program
  • Pancreatic Cancer Copay Assistance Program
  • Parathyroid Disease Financial Assistance Program
  • Paroxysmal Nocturnal Hemoglobinuria Financial Assistance Program
  • Pompe Disease Financial Assistance Program
  • Porphyria Financial Assistance Program
  • Primary Biliary Cholangitis Financial Assistance Program
  • Primary Hyperoxaluria Financial Assistance Program
  • Primary Immunodeficiency Financial Assistance Program
  • Short Bowel Syndrome Financial Assistance Program
  • Thyroid Eye Disease Financial Assistance Program
  • Tumor Induced Osteomalacia Financial Assistance Program
  • Ulcerative Colitis Copay Assistance Program
  • Urea Cycle Disorders Financial Assistance Program

If you do not see your disease program listed above, please click here to visit the Teal Reenrollment Group.

Purple Reenrollment Cycle Now Closed

Reenrollment Cycle: Wednesday, November 2 (12 p.m. ET) through Saturday, November 19 (7 p.m. ET)

The Reenrollment cycle for the Purple Group is now closed. Use the “Reenrollment Hub” button below to check status of your application for Reenrollment.

TAF expects to finalize renewed 2023 program participation by: January 21, 2023.*

Am I eligible to apply for Reenrollment?

You are eligible to apply for 2023 disease program participation if you:

  • are actively enrolled in an eligible Purple disease program;
  • are a U.S. citizen or permanent resident;
  • have been diagnosed with the disease state for which you are applying to reenroll; and
  • have been prescribed an FDA-approved treatment for the disease and have health insurance that covers the prescribed medication.

How do I apply for Reenrollment?

Once the Reenrollment window opens, you can apply for Reenrollment by using one of the following methods:

Text:

If we have your cell phone on file, you may receive your unique Reenrollment link by text.

  • Step 1: Text the following message to (833) 585-0336 any time before November 2: REENROLL23.
  • Step 2: You will immediately receive a confirmation text message.
  • Step 3: On November 2, you will receive a text message with your unique Reenrollment link at 12 p.m. ET.

Email:

If we have your email on file, you will receive an email with your Reenrollment link on November 2. Visit: TAFcares.org/reenroll/purple, select “Reenrollment Hub,” and enter your PIN.

Paper:

If you wish to complete a paper application, please call (833) 343-2148.

Paper applications must be requested and will not be provided prior to November 2.

TAF expects to finalize renewed 2023 program participation by: January 21, 2023.*

* This date is subject to change. You may receive correspondence regarding your renewed 2023 disease program participation by mail, text, or email.